Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Assets Average (2016 - 2025)

Lisata Therapeutics' Assets Average history spans 12 years, with the latest figure at $19.8 million for Q4 2025.

  • For Q4 2025, Assets Average fell 46.03% year-over-year to $19.8 million; the TTM value through Dec 2025 reached $19.8 million, down 46.03%, while the annual FY2025 figure was $26.4 million, 41.19% down from the prior year.
  • Assets Average reached $19.8 million in Q4 2025 per LSTA's latest filing, down from $23.5 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $64.3 million in Q2 2023 to a low of $19.8 million in Q4 2025.
  • Average Assets Average over 3 years is $42.2 million, with a median of $42.9 million recorded in 2024.
  • Peak YoY movement for Assets Average: grew 5.04% in 2024, then tumbled 46.03% in 2025.
  • A 3-year view of Assets Average shows it stood at $56.4 million in 2023, then plummeted by 35.1% to $36.6 million in 2024, then crashed by 46.03% to $19.8 million in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Assets Average are $19.8 million (Q4 2025), $23.5 million (Q3 2025), and $27.1 million (Q2 2025).